NOVAVAX INC Quarterly Cost of Revenue in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Novavax Inc quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q2 2024.
  • Novavax Inc Cost of Revenue for the quarter ending June 30, 2024 was $46.2M, a 17.1% decline year-over-year.
  • Novavax Inc Cost of Revenue for the twelve months ending June 30, 2024 was $359M, a 49.1% decline year-over-year.
  • Novavax Inc annual Cost of Revenue for 2023 was $344M, a 61.9% decline from 2022.
  • Novavax Inc annual Cost of Revenue for 2022 was $903M.
  • Novavax Inc annual Cost of Revenue for 2021 was $0.000.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $359M $46.2M -$9.54M -17.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $369M $59.2M +$25.1M +73.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $344M $155M -$26.8M -14.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $371M $98.9M -$336M -77.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $706M $55.8M -$215M -79.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $922M $34.1M +$18.9M +124% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $903M $182M +$182M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $721M $435M +$435M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $286M $271M +$271M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $15.2M $15.2M +$15.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.